Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.43 USD | +5.93% | -1.38% | -22.28% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.28% | 208M | |
-24.66% | 7.76B | |
+68.65% | 4.33B | |
-3.15% | 2.64B | |
+3.74% | 2.63B | |
-46.17% | 2.16B | |
-15.27% | 1.75B | |
-22.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Morgan Stanley Lowers Biodesix's Price Target to $5 From $7, Maintains Equalweight Rating